header logo image


Page 636«..1020..635636637638..650660..»

Fewer Americans Struggle to Cover Medical Costs, But Many Still Face Burdens – The National Memo

March 12th, 2020 8:51 am

In the United States, the percentage of people having difficulty covering out-of-pocket healthcare costs has dropped in recent years. But a significant portion of the population still struggles to cover medical bills. According to the results of the National Health Interview Survey, sponsored by the U.S. Centers for Disease Control and Prevention (CDC), the proportion of Americans in families having trouble with medical bills dropped to 14.2 percent in 2018, down from 19.7 percent in 2011. Specifically, the share went down by 4.5 percentage points between 2011 and 2015, and then by one point from 2015 to 2018. This indicates that the decrease in the number of families with difficulties paying medical bills has slowed considerably. Still, its not all good news as many of us know from watching the flurry of stories related to healthcare coverage and related legislation.

So how many Americans are currently struggling? A 2019 study from the Journal of General Internal Medicine, based on data from the 20152017 National Health Interview Survey, found that 137 million Americans reported experiencing financial hardship due to medical costs. Regular dental visits twice a year are crucial for patients of all ages, yet many Americans find they cant afford this kind of preventative care or even treatment of existing medical conditions.

According to TD Ameritrade, medical debt is the number one reason why people of all ages think about dipping into their retirement accounts. But often, those accounts dont even contain enough funds to cover medical debt. Bankruptcies in the United States increased in 2016, from 24,797 companies in the first quarter to 25,227 in the second quarter. However, business owners arent the only bankruptcy filers. A 2019 study published in the American Journal of Public Health found that 66.5 percent of personal bankruptcy filings stem from debt due to healthcare costs.

While 50 percent of all workers in the U.S. report having back pain every year, not everyone is equally affected by the cost of healthcare. The aforementioned CDC survey found that African American and Hispanic respondents were more likely than respondents of other races and ethnicities to report difficulties with healthcare bills. Moreover, high costs for one member of a family may impact the entire family. People who are struggling with medical debt may have difficulty paying for other necessities for themselves and their loved ones, including housing, clothing, and food. This can lead to taking money out of retirement accounts and to filing for bankruptcy.

In an attempt to avoid drastic measures like bankruptcy, more people in the United States are using crowdfunding to raise money online for healthcare expenses. Crowdfunding can bring in financial support from family, friends, or even total strangers, thanks to the wonders of the internet. According to a survey conducted by the University of Chicagos National Opinion Research Center, eight million Americans have sought help via crowdfunding on behalf of themselves or a loved one to pay for everything from routine visits to the treatment of rare conditions. In addition, over 12 million Americans report using crowdfunding to assist someone who is not a close family member with healthcare costs. Although crowdfunding campaigns dont always raise as much as is needed, experts believe the trend is an expression of the publics frustration with the ever-expanding costs of medical treatment. That frustration seems to be fueling peoples willingness to help others with medical bills.

As if Americans current struggles to meet healthcare costs werent enough, the new coronavirus, known as COVID-19, may add significantly to peoples medical bills. According to Business Insider, two Americans were recently billed over $3,000 each for coronavirus treatment, despite the fact that tests showed theyre not infected with COVID-19. Only the CDC is able to test for COVID-19 or to authorize other labs to carry out the test and they dont bill for testing. If someone receives treatment for coronavirus from the emergency room or an urgent care facility, they wont be billed for COVID-19 testing, either. But patients must still pay for tests for influenza or other viruses, as well as for the visit to the facility.

Costs due to coronavirus can be considerable, whether the patient has insurance or not. Despite the expansion of coverage under the Affordable Care Act (ACA), 27 million Americans still lack health insurance meaning they will foot the entire bill if they need to be tested or treated for COVID-19. Even those with insurance will have to contend with higher-than-expected bills from a hospital in their network, providing the doctor treating them is outside their insurance network. This is referred to as surprise billing, which affects many patients who visit the emergency room or who receive services in pathology (a department that is likely to be involved in coronavirus treatment). Problems also arise when a hospital in a patients insurance network is full, sending them to another hospital outside their network. In that case, the ACAs out-of-pocket limits for in-network treatment dont apply.

Coronavirus could even lead to more bankruptcies if it causes patients to acquire more medical debt. Unless a patient can arrange for a payment plan with a physician or hospital, bankruptcy may be the best option if they carry a lot of debt and are low income. Even for those receiving regular paychecks from steady employment, a large and unexpected healthcare bill can cause a financial crisis. And patients who are diagnosed with COVID-19 will need to be concerned with lost income if they are quarantined or are slow to recover.

The ACA has brought health insurance coverage to millions of previously uninsured Americans, yet millions more remain uninsured. Whats more, many of those with coverage still struggle with medical debts. While its encouraging that the percentage of families having difficulty with healthcare bills has decreased, the problem remains significant. With people turning to crowdfunding and raiding their retirement savings in order to avoid bankruptcy, and with many others using bankruptcy as their last option, its clear that medical costs in the United States are currently out of control.

The rest is here:
Fewer Americans Struggle to Cover Medical Costs, But Many Still Face Burdens - The National Memo

Read More...

Public Health Partnering Deals, 2014-2020: Full Collection of Deals Signed Between the World’s Pharmaceutical and Biotechnology Companies Since 2014 -…

March 12th, 2020 8:51 am

Dublin, March 11, 2020 (GLOBE NEWSWIRE) -- The "Global Public Health Partnering 2014-2020: Deal trends, players and financials" report has been added to ResearchAndMarkets.com's offering.

Global Public Health Partnering 2014 to 2020 provides the full collection of Public Health disease deals signed between the world's pharmaceutical and biotechnology companies since 2014.

Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor's product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.

The report takes readers through the comprehensive Public Health disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Public Health deals.

The report presents financial deal terms values for Public Health deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.

The initial chapters of this report provide an orientation of Public Health dealmaking trends.

In addition, a comprehensive appendix is provided with each report of all Public Health partnering deals signed and announced since 2014. The appendices are organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc) and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The report also includes numerous tables and figures that illustrate the trends and activities in Public Health partnering and dealmaking since 2014.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Public Health technologies and products.

Report Scope

The report is intended to provide the reader with an in-depth understanding and access to Public Health trends and structure of deals entered into by leading companies worldwide.

Global Public Health Partnering 2014 to 2020 includes:

The report includes deals for the following indications: Addiction, Smoking, Drugs, Alcohol, Health education, Obesity, Preventative medicine, plus other public health indications.

Available deals and contracts are listed by:

Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The report provides comprehensive access to available deals and contract documents for over 250 public health deals.

Analyzing actual contract agreements allows assessment of the following:

Companies Mentioned

For more information about this report visit https://www.researchandmarkets.com/r/ftkpph

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.comLaura Wood, Senior Press Managerpress@researchandmarkets.comFor E.S.T Office Hours Call 1-917-300-0470For U.S./CAN Toll Free Call 1-800-526-8630For GMT Office Hours Call +353-1-416-8900

See the original post here:
Public Health Partnering Deals, 2014-2020: Full Collection of Deals Signed Between the World's Pharmaceutical and Biotechnology Companies Since 2014 -...

Read More...

How used oil analysis can help make the most of your proactive maintenance program – Fleet Equipment Magazine

March 12th, 2020 8:51 am

A proactive maintenance program can help owners and operators prevent breakdowns and costly unplanned downtime. For fleets looking to identify potential mechanical failure before it becomes too serious or expensive to repair, used oil analysis is a vital tool.

Click Here to Read More

Lubricants are the lifeblood of an engine. Used oil analysis is akin to preventative medicinea tool to monitor and identify any potential concerns or issues with the overall health of engine operation. Used oil analysis is a simple three-stage process which involves taking a representative sample of the oil, sending it to a qualified used oil analysis laboratory and then interpreting and, vitally, acting upon the recommendations of the results.

By incorporating used oil analysis into a proactive maintenance program, technical service advisors can evaluate results and trends on an ongoing basis, establishing over time when and where end-users likely costs are going to occur. Identifying trends provides the basis for a better-informed maintenance schedule. For example, regular used oil analysis offers the potential to safely extend oil drain intervals, which provides fleet owners with another opportunity to reduce maintenance costs and keep their vehicles on the road for longer between scheduled maintenance.

Extending drain intervals should always be undertaken in conjunction with an oil analysis program.

Lubricant experts and technical service advisors can share their detailed knowledge and experience of used oil analysis report interpretation; however, its useful for fleet managers to also be able to understand what the results could mean for their fleet. Fleet managers know their equipment and what they need from it, and can foresee when it will be under more pressure and needs to be operating at maximum capacity. By understanding how to analyze the reports, trends and anomalies in results can be identified quickly and maintenance schedules updated as required, in line with commercial demands.

There are several common anomalies to look out for when reading the results of a used oil analysis report. If a report highlighted that coolant or glycol is present in the engine oil, it could be the result of a failing EGR cooler seal, which would require immediate attention from a mechanic and potentially an oil change. The presence of silicon, potassium or sodium could be one of the first signs that this is taking place, so these are important properties to keep an eye on.

Increases in iron and aluminum can be indicators of a failing camshaft, coolant leak attacking the liners, or the engine requiring mechanical adjustment. By spotting the signs early, its much easier and significantly more cost-effective to undertake small maintenance tasks before the issues become too expensive and serious to repair.

One of the most important anomalies to look for is the presence of unburnt fuel combined with an increase in common wear metals (iron, aluminum, lead and copper) as these are signs that the protection of vital engine components may be compromised. In this situation, expert lubricant advice and mechanical expertise should be sought to help resolve the issues.

By incorporating used oil analysis into a proactive maintenance schedule, fleet managers can predict engine wear throughout service life and respond to issues before they become too serious or expensive to repair. Not only can this help manage fleet maintenance, but it can also prevent breakdowns and unplanned downtime. In short, proactive maintenance might be a given for most equipment owners but combining it with simple-to-adapt tools such as used oil analysis can save fleet managers time and money.

This article was contributed by Darryl Purificati, OEM technical liaison for Petro-Canada Lubricants.

See the article here:
How used oil analysis can help make the most of your proactive maintenance program - Fleet Equipment Magazine

Read More...

Obesity rates on the rise in Eau Claire, statewide – WQOW TV News 18

March 12th, 2020 8:51 am

Eau Claire (WQOW) - According to a recent statewide study, obesity rates across Wisconsin and in Eau Claire are on the rise.

That's despite recent city and state efforts to promote healthy eating and active living.

In 2014, the Wisconsin Partnership Program launched its $10 millon, five-year Obesity Prevention Initiative, so why are obesity rates still rising?

"It is cheap entertainment for families to put their children in front of the TV instead of getting them outside and getting active and having that daily physical activity," Janessa VandenBerge, a community health educator with the Eau Claire City-County Health Department, said.

According to the Wisconsin Health Atlas, Eau Claire obesity rates sit at 14% to 22% among children ages five to 17. And for adults, the numbers are even higher. Nearly half of Eau Claire adults are obese: In 2018, the average rates, categorized by zip code, range from 40% to 53%.

Despite local efforts to promote healthy habits, like the Eau Claire Healthy Communities Coalition, and various statewide efforts like Healthy Wisconsin, obesity rates aren't slowing down.

In 2011, nearly 28% of Wisconsin adults were obese. In 2018, 32% were.

Health officials said a lack of commitment can be a big factor.

"It becomes a lifestyle change," Dietitian Heather Krieger said. "You need to foresee yourself doing something forever and not just for a quick fix or that quick weight loss. Knowing that there are resources and you can utilize that is probably the first key."

According to the CDC, obesity can lead to an increased risk for diabetes, heart disease, stroke and even some types of cancer.

"When you're going into your mid-30s, 40s, 50s, a lot of that extra pounds can actually cause things to happen and complications that further will just keep adding," Krieger said.

Krieger added that fad diets aren't the way to go, either, and that they can actually harm your health more in the long run.

Officials said being proactive is what will help our community reverse the upward trend of obesity.

"Healthy eating and being physically active are preventative medicine. We pay the farmer now or the doctor later," VandenBerge said.

Excerpt from:
Obesity rates on the rise in Eau Claire, statewide - WQOW TV News 18

Read More...

Shame Cone is the Latest Coronavirus Prevention Product (For You, Not the Dog) – Mandatory

March 12th, 2020 8:51 am

Necessity is the mother of invention, and coronavirus has made us all a little craftier when it comes to keeping safe. As the COVID-19 outbreak continues to infect hundreds of thousands of people worldwide, most of us are willing to do whatever we have to so that we dont become a statistic. Among the most repeated preventative actions are to wash your hands and stop touching your face. When it comes to the latter, one man has proposed a unique way to keep your filthy paws off your mug: with a shame cone. Traditionally used on pets to keep them from tearing out stitches post-surgery, the shame cone could also prove to be an effective way to slow the spread of coronavirus.

Mike Palmer, the owner of Premier Pet Supply in Beverly Hills, Michigan, recently posted a picture to his companys Facebook page of himself in a shame cone. The cone extends from the neck to the under-eye area, ensuring that not only will your be unable to paw at your own face, but also any droplets from your nose and mouth will be contained by the protective device. While you might get some odd stares if you wear a shame cone out in public, you might get a chuckle or two as well which is just the medicine we need right now in the midst of this terrifying pandemic. Sometimes, in many very serious moments, I think we have to find something to laugh about or something to show that we can still have a sense of humor through it all without overdoing it as far as worry, Palmer told USA Today after the pic went viral. We couldnt agree more.

For more weird news, click here.

For more weird news, click here.

For more weird news, click here.

For more weird news, click here.

For more weird news, click here.

For more weird news, click here.

For more weird news, click here.

For more weird news, click here.

For more weird news, click here.

For more weird news, click here.

For more weird news, click here.

For more weird news, click here.

Follow Mandatory on Facebook, Twitter, and Instagram.

See the original post here:
Shame Cone is the Latest Coronavirus Prevention Product (For You, Not the Dog) - Mandatory

Read More...

Here’s how local schools are talking with families about the novel coronavirus – Visalia Times-Delta and Tulare Advance-Register

March 12th, 2020 8:51 am

(Photo: Getty Images)

Local schools are taking preventative measures against the COVID-19 virus, encouraging good personal hygiene habits and looking to the county health department for future guidance.

Concerns about the novel coronavirus come at the same time as peak flu season, so school staff already have these habits in mind, according toSuzie Skadan, director of health services for Visalia Unified School District.

Skadan said the district has sent out information nearly every week in the past couple months, updating families on best practices.

"It's a good idea you won't get colds or the fluif you follow this, not just coronavirus," Skadan said.

The risk of contracting COVID-19 remains low in Tulare County, according to public health officials. The one Tulare County resident tested for COVID-19 did not have the virus.

"Itis critical that people do not allow fear to drive their actions," said Shawn Elkin,infection prevention manager at Kaweah Delta Medical Center. "Yes, be honest and be vigilant, but don't freak out."

VUSD has shared these guidelines with families:

Skadan said custodial staff is also cleaning classrooms and schools nightly to prevent the spread of germs.

Face masks should only be worn by those who are sick, and not the "worried well," Elkin said.

Skadan agreed, saying that some parents had called the district to see if their child should wear a mask but that masks were "to protect students who are ill" and not to be used as a "faceguard for all students."

School sitesare leaning away from naming the novel coronavirus in their preventative efforts.

"We continue to push wash your hands, cover your mouth, all those kinds of things we do with the normal flu," said Loretta Bryant, principal at Annie R. Mitchell Elementary School."We don't specify anything to do with the coronavirus."

"We don't really bring it up," Bryant added. "We are here to engage in learning, not in panic."

Skadan said district staff has discussed how to proceed if the virus spreads to Tulare County.

"We have plans in place, should something happen, that we'd be able to move accordingly," Skadan said."We follow the direction of the health department."

Visalia Unified School District is sharing this poster from the Centers for Disease Control and Prevention.(Photo: Centers for Disease Control and Prevention)

Reach reporter Kyra Haasby emailat khaas@visaliatimesdelta.com or find her onTwitter@kc_haas.

Get alerts and keep up on all things Tulare County for as little as $1 a month.Subscribe today.

Read or Share this story: https://www.visaliatimesdelta.com/story/news/2020/03/09/heres-how-local-schools-talking-families-covid-19/4954325002/

Link:
Here's how local schools are talking with families about the novel coronavirus - Visalia Times-Delta and Tulare Advance-Register

Read More...

A coronavirus outbreak along the US-Mexico border could be devastating (Opinion) – The Yucatan Times

March 12th, 2020 8:51 am

Asylum seekers at Mexico - USA border crossing (Photo: Al-Jazeera)

The U.S. government hasadvisedAmericans to wash their hands obsessively, avoid close contact with others and stay home as much as possible to prevent the spread of COVID-19, the disease caused by the novelcoronavirus, which has infected more than1,000 peoplein the country. Butthousands of migrants seeking asylum in the United States cant follow these instructions since the Trump administration has forced them to wait for their court dates in overcrowded and unsanitary camps and shelters near the border.

Without the governments help, volunteer doctors in Mexican border towns told HuffPost they are scrambling to take preventative measures to stave off a coronavirus outbreak. But if the disease enters these congested environments, it could spread like wildfire and lead to deaths, said Helen Perry, the executive director of the nonprofit Global Response Management who has been coordinating medical efforts in Matamoros.

The potential for a devastating outbreak in those circumstances is really great, saidDr. Ranit Mishori, a professor of family medicine at Georgetown University, adding that these migrants face a perfect storm of factors. Theyre marginalized, they have no access to care and theyre so vulnerable. People can absolutely die.

Since January 2019, the Trump administration has turned back almost 60,000 asylum-seekers under a program known as Remain in Mexico. On Wednesday, the Supreme Courtoverrodea lower courts decision to block the program, which hasforcedtens of thousands of people to live for months in dangerous Mexican border towns where crime is rife and medical resources are scarce.

The shelters and tent camps in border cities such as Matamoros, Tijuana and Ciudad Jurez are playgrounds for viral illnesses like COVID-19. In Matamoros, roughly2,000 peoplelive in tents packed together along the Rio Grande. They are constantly in groups, eating together and waiting to use portable showers and toilets. Their only access to water is from big containers brought in by volunteers.

You cant just tell someone, Hey, just dont come out of your tent for a couple days, Perry said. The thought that theres going to be any kind of quarantine is pretty limited.

Theyre marginalized, they have no access to care and theyre so vulnerable. People can absolutely die.Dr. Ranit Mishori, professor of family medicine at Georgetown University

There are currently onlysevenknown cases of the coronavirus in Mexico, and the biggest threat of infection comes from American volunteers, physicians told HuffPost.

But as more doctors and nurses cancel their trips across the border to aid the asylum-seekers, immigrants are being cut off from their only access to health care. Dr. Hannah Janeway, who helps run the Refugee Health Alliance, said so many volunteers have canceled trips to Tijuana that there are three weeks between March and April when the Refugee Health Alliance wont have enough U.S. doctors and nurses to staff the medical clinic.

Click here to read full article by Angelina Chapin, reporter for the HuffPost

comments

Read this article:
A coronavirus outbreak along the US-Mexico border could be devastating (Opinion) - The Yucatan Times

Read More...

What to do if you have a relative in a nursing home during the coronavirus outbreak – Insider – INSIDER

March 12th, 2020 8:51 am

As the infection rate from the coronavirus climbs, it's natural to want to comfort relatives who are most vulnerable to the virus, such as older people in nursing homes.

But in a bid to control the spread, industry leaders announced on Tuesday that all care homes should limit visits.

Already, there have been 18 coronavirus-related deaths at a long-term care facility in Washington called Life Care Center, and 70 of the 180 staff members at the facility are sick, according to the New York Times.

Since the older people at Life Care Center and similar facilities often have underlying health conditions, they're more susceptible to developing severe cases of COVID-19, the disease caused by the coronavirus, especially since they live in close quarters with other susceptible people.

Although it can be disheartening to have little or no physical access to an older loved one in a nursing home, there are ways to feel close and provide support from a distance.

You can still create emotional closeness and comfort by checking in on your elderly relatives through a phone call or video call.

Dr. Sean Morrison, the chair for the Brookdale Department of Geriatrics and Palliative Medicine at Mount Sinai Hospital, said it's also important to have faith and trust in the staff of care facilities because they're trained to offer much-needed support when families aren't available.

"A lot of that comfort is provided on a regular basis when we're not facing a COVID-19 challenge," Morrison told Insider. "So I think to reassure families of people in long-term care and nursing homes that compassion is there and their loved ones will be well cared for," is important.

Morrison also said families should urge their relatives in nursing homes to form bonds with the staff if they haven't already because that can offer them companionship during times when visitations aren't allowed.

You could also send your relative a thoughtful care package with their favorite snacks, entertaining books, or a sweet message.

Crystal Cox/Business Insider

In the event that you can visit your loved one, you should only do so under specific circumstances.

If you've recently traveled to any of the countries on the CDC's travel restrictions list, for example, you should stay home. Since the coronavirus is spreading in the US now too, Morrison said anyone who has respiratory infection symptoms like a cough or sore throat should also abstain from visiting, because those symptoms, while linked to many illnesses, are also symptoms of COVID-19.

If you're healthy and haven't traveled to the countries in question, you're set to visit. Before you go to the facility to see your relative, Morrison said to wash your hands for 20 seconds with soap and warm water.

Once at the facility, be sure to wash your hands or use hand sanitizer after touching any door knobs. If using an elevator, Morrison suggested pressing the elevator buttons with your elbow.

"Once you are with your loved one, people should avoid hand-to-hand contact, hugs, and kisses," Morrison said. "What we know so far is that it is not an airborne virus. It's transmitted through respiratory secretions either by directly breathing in droplets from someone who has coughed and sneezed within 6 feet of you, or through touching a surface on which droplets recently fell and then self-infecting yourself from your hands."

Whether you get to set foot in the nursing home or not, one way to make sure your loved one is safe is to ask the nursing home's staff about the current cleaning protocols, either in person or over the phone.

Morrison said these facilities should have daily temperature and symptom checks for both residents and staff and have a system in place where staff who feel ill stay home from work.

He also said the facility should keep their staff assigned to specific teams rather than moving them around. That way, they're not moving across different units or buildings within the facility, which could contribute to germ spread, Morrison said.

You should also ask about group dining and events in the facility.

"Social distancing is challenging [in nursing homes] because what you also are worried about is the sense of isolation, particularly for people who have cognitive impairment or dementia within a nursing home," Morrison said. "But limiting group activities to small numbers, and group dining should be quite small rather than large group dining," to keep residents protected.

Lastly, facilities should have signs that ask anyone with respiratory illness symptoms to stay outside and the front desk should ask visitors about their recent travels.

If you're worried by any of the cleaning protocols or practices, Morrison said you should contact the local state health department to file a complaint.

Although it may feel like the best option to remove your relative from their nursing facility, Morrison said these places are often best equipped to care for people with unique or severe conditions.

"In an ideal world, somebody with functional impairment, cognitive impairment, or a serious medical illness is probably safer at home with unlimited caregivers and limited exposure to other people with serious," Morrison said.

"That being said, most people who are in nursing homes in this country are there because they or their families don't have the resources to provide that type of care at home. And so they are really [in the nursing home] because there is no other institution, no other place that can meet their needed level of care."

Link:
What to do if you have a relative in a nursing home during the coronavirus outbreak - Insider - INSIDER

Read More...

Coronavirus: What you need to know – Fox News

March 12th, 2020 8:51 am

As coronavirus continues to spread across the globe, here is everything you need to know about the deadly virus.

What is coronavirus?

Coronaviruses are a family of viruses named after their appearance, a crown, said Dr. Mark Rupp, an infectious disease expert at the University of Nebraska Medical Center.

How dangerous is coronavirus?

Most coronaviruses cause mild symptomsthat patients easily recover from.

What is COVID-19 and how is it different from other coronaviruses?

COVID-19 is not the same as other coronaviruses that commonly circulate among humans and cause mild illness, like the common cold. Some cause illness in people, and others, such as canine and feline coronaviruses, only infect animals. Rarely, animal coronaviruses that infect animals have emerged to infect people and can spread between people, which is suspected to have occurred for the virus that causes COVID-19.

MERS and SARS are two other examples of coronaviruses that originated from animals and then spread to people.

What are the symptoms?

Many symptoms of COVID-19 and influenza overlap, here's how to spot the differences.

When did the outbreak start?

The World Health Organization's China office says it began receiving reports in late December of a mysterious virus behind a number of pneumonia cases in Wuhan, a city in eastern China with a population of roughly 11 million people.

How is coronavirus transmitted?

According to the Centers for Disease Control and Prevention (CDC), coronaviruses are common in camels, cattle, catsand bats. Person-to-person transmissions are thought to occur when an infected person coughs or sneezes, similar to how influenza and other respiratory pathogens spread.

How often are people hospitalized for it?

The risk of contracting coronavirus remains low for most Americans, U.S. Surgeon General Dr. Jerome Adams said.

How can you protect against getting it?

You can protect yourself from coronaviruses by following basic wellness practices.

How do I sanitize surfaces?

Keeping your home and surfaces clean using the correct disinfectants is crucial in preventing its spread.

How long can it survive on surfaces?

The novel coronavirus may be able to live on surfaces, namely metal, glass or plastic,for up to nine days if it resembles some of its other human coronavirus-causing cousins, that is.

Are you washing your hands correctly?

There are a few general rules to follow when it comes to washing your hands thoroughly, including for how long you should keep them under runningwater.

How do I make my own hand sanitizer?

If soap and water arent available, hand sanitizer is the next best option namely if it contains at least 60 percent alcohol, the CDCsays.

Do face masks help?

Surgical masks will not prevent your acquiring diseases, said Dr. William Schaffner, a professor of preventive medicine and infectious diseases at Vanderbilt University, and the medical director of the National Foundation for Infectious Diseases.

Who is most at risk?

Young people, senior citizensand those with immune deficiencies could have an acute reaction if exposed to the virus.

Does it affect pregnant women?

The health agency said that while risk to the American public remains low at this time, pregnant women should continue to engage in usual preventative actions to avoid infection, such as washing hands often and avoiding contact with people who are sick.

How do you care for a relative who has it?

Even if the patient does test positive, it can be considered safe to continue supporting them with some extra precautions.

How do you test for it?

Before being tested for thedeadly virus, patients must first answer a series of questions.

How do you treat it?

Fox News received an in-depth look at the new disease fromDr. Debra Chew, a former epidemic intelligence officer for the Centers for Disease Control and Prevention(CDC) and an assistant professor of medicine at Rutgers New Jersey Medical School.

Is there a cure?

Health agencies recommend patients receive supportive care to relieve coronavirus symptoms.

What happens after you recover from it?

A negative test doesn't always mean the patient is free of the virus

Can you get it through packages?

Surgeon GeneralJerome Adams said, There is no evidence right now that the coronavirus can be spread through mail.

How do you travel during the outbreak?

As the coronavirus risk grows globally, being smart about planning travel will help you stay safe.

Tips on how to talk to your kids about coronavirus

Its important to remember that children take cues from the adults that surround them, so how you address the virus at home may reflect in their behavior.

How does coronavirus compare to other outbreaks?

SARS and MERS came from animals, and this newest virus almost certainly did, too.

Is coronavirus Disease X?

The novel coronavirus has led one expert to say that it fits the criteria for Disease X,a designated placeholder on theWorld Health Organizations (WHO)list of illnesses that have potential to reach international epidemic levels.

Is coronavirus here to stay?

Dr. Robert Redfield, the director of theCDC, said the virus is probably with us beyond this season, beyond this year.

Coronavirus: What to know about the mysterious illness

Coronaviruses are a family of viruses named after their appearance, a crown, said Dr. Mark Rupp, an infectious disease expert at the University of Nebraska Medical Center.

There are many types and a few are known to infect humans. Some cause colds and respiratory illnesses, while others have evolved into illnesses such as Severe Acute Respiratory Syndrome (SARS) andMiddle East Respiratory Syndrome (MERS).

SARS began in China and infected some 8,000 people during a 2002-2003 outbreak. Approximately 770 people died after it spread to other cities and countries.

"This is the third kind of novel coronavirus that we're having experience with that can cause lower respiratory tract disease," Rupp said Tuesday.

In some rare cases, the virus can be transmitted from animals to humans but are typically transferred during contact between humans, according to the CDC.

How dangerous is coronavirus?

The coronavirus, or what is now known as COVID-19, began at an animal and seafood market in the city of Wuhan and has since spread to several other countries, including the United States. The illness is now said to be transferable between humans.

As news of the virus spread and death tolls began to spike, many have begun to questionhow dangerousthe new outbreak is. Coronaviruses, which get their name from their crown-like appearance, come in many types that cause illnesses in people and animals.

Most coronaviruses cause mild symptoms, such as the common cold that patients easily recover from. Other strains of the virus -- such asSevere Acute Respiratory Syndrome (SARS) andMiddle East Respiratory Syndrome (MERS) -- can cause pneumonia and possibledeath.

SARS killed 770 of8,000 people infected in 2002-2003. MERS killed about three or four out of every 10 people infected, the Centers for Disease Control and Prevention (CDC) said.

In an effort to curb the spread of the disease (human coronaviruses are passed through coughing and sneezing, close personal contact, touching objects with the virus on it and then touching the mouth, nose or eyes before washing your hands, according to the CDC), the city of Wuhan shut down all air and train traffic. On Jan. 30, The World Health Organization (WHO) declared the coronavirus outbreak a public health emergency just days after WHO officials announced they would hold off doing so.

"The main reason for this declaration is not because of what is happening in China, but because of what is happening in other countries. Our greatest concern is the potential for the virus to spread to countries with weaker health systems, and which are ill-prepared to deal with it," WHO Director-GeneralTedros Adhanom Ghebreyesus saidat the time.

Meanwhile, CDC officialsmonitoring the outbreak maintain that the risk to the American public is low, despite the 15 confirmed cases of the virus that have occurred in the U.S. in recent weeks.

Recently, the CDC and Customs and Border Protection (CBP) expanded passenger screenings to include 20 U.S. airports, which take in "90 percent of all passengers from China," Vice PresidentPence said.

In recent weeks, Sen. Tom Cottonraised concerns about a Chinese cover-up of the virus as it spreads to various countries.In a letter to the Department of Health and Human Services Secretary Alex Azar, Cottonurged Azar to vet information from China, given its history of cover-ups during the SARS outbreak. At the time, China didn't announce the disease to the public until five months after it began.

"If you have reason to believe that U.S. officials are being provided with false or misleading information about the disease from Chinese government officials, I ask you to notify Congress immediately," Cotton wrote.

How coronavirus differs from flu: Symptoms to watch for

Officials are urging anyone who develops possible symptoms of the novel coronavirus to contact health care providers to inquire about next steps and possible testing, but with millions infected by the influenza virus in the U.S., many are wondering how to tell the difference between the two.

There is so much overlap in symptoms between flu and COVID-19 but a couple of hallmark differences do exist, Dr. Caesar Djavaherian, co-founder of Carbon Health, told Fox News. Influenza tends to cause much more body pain and the COVID-19 virus tends to feel much more like the common cold with fever, cough, runny nose and diarrhea. However, in a small portion of the population with either COVID-19 or influenza, symptoms progress to kidney failure and respiratory failure.

By the end of February, the Centers for Disease Control and Prevention (CDC) estimated that at least 32 million cases of the flu were reported in the U.S., resulting in 310,000 hospitalizations and 18,000 deaths. For the coronavirus, by March 3 the number of confirmed cases in the U.S. had reached 100, including several presumptive positive cases and 24 in repatriated Americans. At least nine COVID-19 patients have died.

But several health officials, including New York Gov. Andrew Cuomo, have cautioned that healthy Americans who contract COVID-19 may not even know that they have it, and will heal without any treatment. Others say their experience will be similar to that of a common cold, but for those with underlying health conditions, the virus can be severe.

The differences arise in the very small portion of the population who are at risk because of their lung or heart conditions whose lungs can fill with fluid or go into kidney failure and unfortunately, eventually die, with COVID-19, Djavaherian said.

One of the most imperative ways to stop the spread, experts say, is to avoid contact with a sick person, and to practice your own good hygiene. Part of that includes staying home when youre sick and thoroughly washing hands.

If you are sick, monitor your symptoms daily, and when your common cold turns into a deep unrelenting cough and then shortness of breath, those are the signs that we worry about and the signs that require patients to get medical attention right away, Djavaherian said. They may be from pneumonia but in a very, very small group of patients, maybe a COVID-19 infection that has gone into the lungs.

Djavaherian said its imperative to call your health care provider ahead of time to share your symptoms and concerns so that they can prepare the appropriate tests and protect others from potential exposure.

I also recommend using telemedicine, where you can see a doctor via phone or video, to get your questions answered from the comfort and safety of your own home without putting others or yourself at risk, he said.

How did the coronavirus outbreak start?

The World Health Organization's China office says it began receiving reports in late December of a mysterious virus behind a number of pneumonia cases in Wuhan, a city in eastern China with a population of roughly 11 million people.

Researchers suspect the virus originated at a seafood market in Wuhan, where wild animals, including birds, rabbits, bats, and snakes are traded.

It was initially believed the virus came from snakes. But a research paper by a team of virologists at the Wuhan Institute for Virology suggests that the coronavirus more likely came from bats, which was also the source of the SARS outbreak.

Bats are known to carry multiple viruses without getting sick, according to the New York Times, which said they have caused human diseases in Africa, Malaysia, Bangladesh and Australia, and are thought to be the reservoir for Ebola.

Authorities shut down the market on January 1. But by then, the virus had spread beyond the market and was being transmitted between people.

On January 12, Chinese health officials shared a genetic sequence of the virus with other countries to better diagnose the strain in patients.

A committee of the WHO on Thursday declared the outbreak a global emergency. The U.N. health agency defines an international emergency as an extraordinary event that constitutes a risk to other countries and requires a coordinated international response.

Such a declaration usually brings greater money and resources but also compels governments to restrict travel and trade to affected countries. The announcement also imposes stricter requirements for disease reporting on countries.

How is coronavirus transmitted?

This virus has spread at unprecedented scale and speed, with cases passing between people in multiple countries across the world, said Dr. Jeremy Farrar, director of Britains Welcome Trust. It is also a start reminder of how vulnerable we are to epidemics of infectious diseases known and unknown.

The United States and South Korea confirmed its first cases of person-to-person spread of the virus.

Scientists say transmission of the virus is most likely between people with close contact, like families. But there have been reported instances of people who may have had less exposure to the virus in Japan and Germany.

The coronavirus has now infected more people in China than were sickened there during the 2002-2003 outbreak of SARS. Virologists believe it originated at a seafood market in the eastern Chinese town of Wuhan when someone or a group of people came into contact with wild animals being traded there.

According to the Centers for Disease Control and Prevention (CDC), coronaviruses are common in camels, cattle, cats, and bats. Person-to-person transmissions are thought to occur when an infected person coughs or sneezes, similar to how influenza and other respiratory pathogens spread.

Other ways the virus may spread from an infected person to others is through touching or shaking hands, or if a person touchesa surface with the virus on it, then touches theirmouth, nose, or eyes before washing their hands, the CDC says.

But despite the WHOs declaration of emergency, the immediate heal risk to the general American public still remains relatively low.

Surgeon general say risk of coronavirus remains low, most people will not need hospitalization

The risk of contracting coronavirus remains low for most Americans, U.S. Surgeon General Dr. Jerome Adams reassured.

See original here:
Coronavirus: What you need to know - Fox News

Read More...

What Jason Hope Says About New Longevity Research – HealthTechZone

March 12th, 2020 8:51 am

Throughout the past decade, various topics related to stem cells have made headlines across all platforms. From being hailed as the most innovative method for eradicating specific diseases, to being protested by various groups and organizations, the use of stem cells has gained national attention repeatedly. With promising initial scientific findings, and avid researchers aiming to solidify the presence of stem cell usage in the realm of science on a normalized basis, increasing numbers of startups, biotech giants, and independent companies are forging ahead with stem cell-related projects. As global connectivity, technological advancements, and the marriage between medicine and technology continues to evolve swiftly, Jason Hope sees stem cells will undoubtedly remaining in the spotlight.

Over 20 years ago, scientists successfully extracted the first human embryonic stem cells, and effectively grew these cells in a lab setting. The remarkable feat of being able to successfully grow the parent cells, which essentially allow for the growth of new cells in the body, was a hopeful moment for the medical sector involved in creating effective regenerative treatments for conditions like heart disease, Alzheimers, stroke, and Parkinsons Disease. Using basic reasoning, the successful regeneration of parent cells could provide the regeneration of undesired cells, leading to anti-aging results, or effective care for many age-related conditions that deteriorate the body over time.

Though this initial breakthrough was promising, the scientific community has not yet made significant strides in bringing stem cell therapy to market in a way that is well-researched, backed by medical associations, and commonly accepted by the scientific community. In fact, the only readily utilized stem cell treatments are related to successfully growing blood cells from matching donors for patients with various blood disorders. According to entrepreneur, philanthropist, and expert in the realm of anti-aging and longevity, Jason Hope, these initial utilization of stem cells are commendable, but require a lot more research in order to maximize the potential widespread benefits of stem cells in medicine.

Hope, who has devoted much of his philanthropic endeavors within the medical industry via groups like the SENS Organization, recognizes that most stem cell implementations are rightfully considered experimental until appropriate research, testing, and development can occur. As an expert in the realm of anti-aging, and the championing of increasing health throughout a lifetime, Jason Hope recognizes the potential distrust that can be formulated by the general public as a result of eager companies making lofty claims or promoting potentially faulty treatments not yet fully vetted by the medical community. Thus, while he remains avidly enthralled by the potential maximization of stem cell therapies, hope supports the long-term research needed to safely, successfully, and effectively generate breakthrough stem cell treatments.

Providing continued backing for the extensive research completed at the SENS (Strategies for Engineered Negligible Senescence) Organization, Hopes contributions aid in the research aiming to create preventative treatments for degenerative diseases and utilizing breakthrough science to increase the overall long-term quality of life for individuals. Instead of focusing on the treatment of symptoms and the disease throughout the progression of the condition, the scientists at SENS work to examine ways to successfully prevent the disease from happening. Through this boundary-pushing work, a lot of their research focuses on stem cell intervention. According to Hope, stem cell treatments for Parkinsons Disease are now in the second stage of clinical trials at SENS. While the process of undergoing such extensive trials may appear slow, it is crucial to maintaining overall public support via successful treatment launches and promising in terms of the long-term possibilities linked to stem cell treatments.

In addition to the research being conducted by SENS, preliminary medical studies are being conducted with a myriad of uses for stem cells. Experimental stem cell transplants of retinal cells were recently utilized in a small research study of macular generation, providing initially promising results for the handful of patients who have received artificially generated retinal cells. Elsewhere, scientists have begun to explore ways to minimize potential rejection of stem cells in organs like the liver, through maximizing the most conducive environment for stem cells to thrive. While these slow-moving vehicles of change are less prominent than startups promising the proverbial Fountain of Youth via experimental stem cell treatments, these medically sound research studies are forming the backbone of stem cell treatment for the future.

As with all scientific and medical innovations, Hope also recognizes the potential risks, hurdles, and roadblocks within the growing field of stem cell research, and integration into medicine. From supply chain concerns to potential long-term side effects, and the risk of overly eager startups making too-lofty claims, Hope understands that the road to the everyday utilization of stem cells remains lengthy and potentially bumpy. However, the proverbial juice may very well be worth the squeeze in this example. As stem cells harvest the potential power to overturn the degenerative effects of some of the most prominent diseases, allow individuals to maintain active health for elongated periods of time, and increase the quality of life for countless individuals, expanding upon the initial promising research is potentially a pivotal point for the medical community and humankind. Though the road to successful scientific integration of stem cells is long, the potential healthcare benefits are limitless, and according to industry experts like Jason Hope, worth investing in, exploring, and championing.

About Jason Hope

An avid entrepreneur, investor, and philanthropist, Jason Hope is a futurist involved in the championing of technological advancement, community involvement, and innovative medical interventions. Deeply passionate about the anti-aging, longevity, and human advancement niche of biomedicine, Hope remains actively involved in various scientific organizations.

After receiving a degree in Finance from ASU, and a subsequent MBA from ASUs W.P. Carey School of Business, Hope developed a successful mobile communications company. Professionally, he currently focuses on investing in startups and developing grant programs for small businesses.

Follow Jason Hope:

LinkedIn | Facebook | Twitter | Medium

View original post here:
What Jason Hope Says About New Longevity Research - HealthTechZone

Read More...

‘Don’t panic Mr Mainwaring!’ – Martin Field intends to keep calm and carry on during this containment phase of coronavirus – Salisbury Journal

March 12th, 2020 8:51 am

Dont panic. There are echoes of Dads Armys Corporal Jones as governments around the world struggle to give balanced advice to their citizens. On the one hand, the death rate from coronavirus is relatively low, more dangerous than seasonal flu, but much less deadly than other high profile outbreaks, such as Ebola, SARS and MERS. On the other, news reports are alarmist; its arrived in Wiltshire and Hampshire; a vaccine is at least a year away and if we all panic, stay at home and schools close, the economy and country will grind to a halt!

Not surprising that Mondays advice from the government was to keep calm and carry on, with a hint that shortly those with mild flu-like symptoms will be asked to stay at home and isolate themselves for a week. Meanwhile public events go ahead and schools remain open. But the British public are a fickle lot. We buy a lottery ticket when we havent got a cat in hells chance of winning; we worry about flying when were more likely to be injured driving to and from the airport while supermarkets are cleared of toilet rolls, paracetamol and hand sanitisers (soap and water is just as effective) as talismans to keep infection at bay. One interviewee told a journalist All this panic buying; its ridiculous. Weve just stocked up on a few toilet rolls and medicines

We laugh at Corporal Jones, but the thing that made Dads Army so funny, was that we were laughing at ourselves. My favourite catch phrase was Captain Mainwarings I wonder whod be the first to spot that one. after yet another blunder; I find myself using it repeatedly.

"Theres a large epidemic of coronavirus anxiety, claimed Dr William Schaffner, a leading expert on preventative medicine and infectious disease. "I think people ought to take a deep breath and spend a little more time planning what to do if the coronavirus really came into their community and they had to undergo what we call social distancing, which is separating themselves from other people. If you do this now when youre more calm, it works much better when you really have to apply it rather than planning in a more anxious moment later on.

The best medical advice is to channel our anxious energy away from loo rolls and into doing things to prevent Coronavirus spreading. Wash your hands, particularly before eating, after using public transport or when entering somewhere where there may be vulnerable people.

And begin to set out your own plans for social distancing that will reduce the risk of transmission and exposure; think where you will and wont go; whats essential in your life and what you can do without. Above all, follow Jones' advice dont panic

More:
'Don't panic Mr Mainwaring!' - Martin Field intends to keep calm and carry on during this containment phase of coronavirus - Salisbury Journal

Read More...

Should Black America be worried about Coronavirus? – TheGrio

March 12th, 2020 8:51 am

As the new coronavirus aka COVID-19 makes its way around the planet and the United States with global infections over 100,000 and current death toll upwards 3800, health officials and politicians statewide and worldwide are declaring emergency.

Even though the common flu kills globally up to over 600,000 people annually, the super contagious coronavirus with a relatively longer latency period is somehow outshining that fact, tapping into a global fear that comes with being a new pandemic.

Both in China and Italy, millions are being quarantined, stocks markets are dipping, oil prices are falling, SouthXSouthwest canceled. Cruise ships are being held at bay. And even Senator Ted Cruz is voluntarily quarantining himself after a one-minute contact with someone who tested positive to the virus. With this global backdrop, one must wonder if we are ready for all of this.

READ MORE: Waffle House employee tests positive for Coronavirus

Juliette Keyyem, former department of Homeland security official, in her essay, The U.S. Isnt Ready for the Whats About to Happen for The Atlantic, the sub-headline reads:

Even with robust government response to the novel coronavirus, many people will be in peril. And the United States in anything but prepared.

And on the other hand, a piece in the TheConversion.com offers Ten Reasons you ought not to panic.

Whether all of this proves to be a very sad historical catastrophe or a massive overreaction, this is nevertheless a serious moment and begs the question: are Black people ready and what can we do to maximize preparedness in a world where Black life and health collectively struggles against poverty, muted healthcare access, disproportionate pre-existing issues, and history of medical racism.

Black folks have a particular history with contagion and medical racism, since the days of slavey and colonialism when the white man exposed us to all sorts of new diseases. George Washington wore dentures made from the teeth of African people, and enslaved Black women were used as human guinea pigs in gynecological experiments.

Whats more, the Tuskegee experiment is a reminder of how Black men were once part of a government study, and the victims of a racist conspiracy that left them untreated and ill with Syphilis for years. That history continues to fuel suspicions of the medical profession within the Black community.

Over a century ago, long before the current coronavirus outbreak, there was another pandemic with present-day implications. The 1918 flu epidemic killed 675,000 Americans, and between 50 and 100 million people globally, more than the total number of casualties in World War I.

READ MORE: New York State prisoners to make hand sanitizers to combat coronavirus

One of those who succumbed to the flu that year in the most curious of ironies was the grandfather of Donald Trump. One of the reasons why the flu was so deadly and spread so widely is that in America and Europe, the news media and political leaders hid the truth.

Through censorship and pressure on public health officials to lie, the public was not informed of the dangers. Woodrow Wilson, the racist president of his day who contracted the flu himself, made no public statements about the pandemic, and even enacted a law making it a crime punishable by 20 years in prison to publish information that could hurt the war effort.

Meanwhile, 1918 was the height of segregation and racial violence, when Black people were politically disenfranchised and denied health services, as white supremacy maintained theories about their biological inferiority and compromised their health, safety, education and socioeconomic status. In response to these circumstances, the black community mobilized, created institutions and hospitals and took care of their own sick people.

Theres lots of reasons for distrust around medicine for black people, and the distrust of medicine is not monolithic. There are reasons why certain kinds of people are afraid of medicine, said Dr. Steven Thrasher, assistant professor atthe Northwestern University Medill School of Journalism, Media, Integrated Marketing and Communications told theGrio.

Some are legitimate, some are not. But we have a long history of being tested on against our will, and also at the same time of being disproportionately harmed by diseases and outbreaks, and so I think its important to take this stuff seriously.

Im not aware yet of racial breakdowns of how this is playing out nationally, but certainly in terms of my own research which is primarily about HIV and police violence and gun violence, these things always disproportionately impact us. So Im particularly worried, he added.

READ MORE: LeBron refuses to play if Coronavirus keeps fans barred from arenas

Today, faced with a president who lies to your face about the gravity of the coronavirus crisis, the Black community must be vigilant. There is no telling what Trump will do to exploit the pandemic to further his white supremacist policies, lest you forget the 70,000 migrant children already locked up in ICE detention centers, including Black children from Africa, the Caribbean and Latin America.

Understanding the context of American medical racism should inspire an awareness and diligent plan of action especially when confronting a potentially deadly infectious disease such as COVID-19.

First we must all do our part in minimizing the spread of this virus. According to the World Health Organization, the advice is: we should wash our hands frequently, maintain social distance, avoid touching your face, practice good respiratory hygiene, and if you have fever, cough and hard breathing seek medical attention.

Secondly, separate facts from fiction. Just because Black folks are not the face of the coronavirus, does not mean we have special protection. The low numbers here and in Africa might be more about Black folks conservative practice of traveling outside their country and general segregated domestic travel patterns in the U.S.

In fact, BBC reportsthat Africa has more than 30 cases including countries such as Egypt, Nigeria and South Africa.

The COVID-19 gravely affects seniors and people with pre-existing conditions, such as compromised immune system, hypertension, cardiovascular diseases and diabetes. As Bloomberg news reported, top Coronavirus doctors in Wuhan, China, say high Blood pressure is major death risk. Since hypertension affects African Americans in higher numbers we must pay attention.

Contracting and falling ill to the coronavirus cannot be the way you find out you have diabetes or heart disease. This is why having access to regular medical care to know your pre-existing conditions is a smart way to protect oneself and ones community from the harm and spread of infectious diseases like the coronavirus.

So areas in our community where medical care is especially lacking, like in prisons and the homeless population, we should be intelligently worried. Dr. Thrasher also points out that, homelessness is a huge driver of incarceration, and those are two ways where the coronavirus could affect Black people very badly.

When we think of world changing disasters, we think of big things, like hurricanes, tornadoes, earthquakes or maybe even some gigantic meteorite headed our way. But history has shown us repeatedly that it is the little things, the microscopic elements that we need to really worry about.

Whether it is the black plague, influenza, polio, HIV, infectious diseases are beyond scary, testing humans capacity and social politics for survival. And while natural disasters and pandemics may create some level of surface unity around a common enemy, it also promotes systemic privileges, and exposes the most vulnerable among us, when the stakes are at their highest.

Chances are great that COVID-19 will be contained and that a vaccine will be found and the biggest casualty here will be our fleeting fear of extinction. Chances are also great that this new coronavirus will expose the best and worst of what lurks in the cytoplasm of our humanity.

And whether the source of the pandemic is lab created or natural, medical racism and mistrust are real things, and so we must be prepared, nevertheless for now and for the future. The best way to do that going forward is to advocate for the best preventative care and healthcare system access, before the cough, before the chest pain, before the hospital visit and before the grave.

Opinion articles reflect the thoughts and opinions of the authors and do not necessarily reflect the opinions of theGrio and its staff.

Go here to see the original:
Should Black America be worried about Coronavirus? - TheGrio

Read More...

Implant that gives failing hearts a boost! – Infosurhoy

March 12th, 2020 8:51 am

An electrical device the size of a watch could revolutionise the treatment of heart failure, a condition that affects nearly a million people in the UK.

The implant releases an electric current to help strengthen and even regenerate a weak or damaged heart muscle, and so improve its pumping action. This pushes more blood around the body, helping patients exercise more easily and enjoy a better quality of life.

Heart failure occurs when the muscle becomes weakened, typically as a result of heart disease, high blood pressure, irregular heart rhythms or the damage caused by a heart attack.

Symptoms include breathlessness, feeling permanently tired and having swollen ankles these worsen over time.

A recent study from Keele University showed that people who have heart failure have a higher risk of premature death than those with common types of cancer.

Treatment involves managing the symptoms there is currently no cure and ranges from drugs that widen blood vessels to improve blood flow, to surgery to bypass clogged arteries, and heart transplants.

Although transplants can be highly effective, there is a shortage of donor organs.

The new device may help those who dont respond to medication and could delay the need for a heart transplant, or avoid the need altogether.

It consists of a small implanted generator, which is attached to two electrodes.

One of the electrodes, in the form of a mesh patch, is attached to the outside of the heart muscle, while the other sits in the left ventricle, one of two large chambers towards the bottom of the heart that collect and expel blood.

The implant is inserted under general anaesthetic in a procedure that involves only two small incisions in the chest. It takes around an hour.

Research in animals has already shown that improving the strength of the hearts contractions can cause muscle cells to regenerate and work more effectively.

Developed by Germany-based Berlin Heals, the new device has been successfully used in humans for the first time in hospitals in Austria and Serbia. After three months, the first patient treated with the device is already showing signs of regeneration.

Dr Punit Ramrakha, a consultant cardiologist at Hammersmith Hospital, says the device may be another option for patients with advanced heart failure who havent responded to conventional therapy.

But he adds: The risks of the procedure which requires a general anaesthetic may well be outweighed by the clinical benefits, and we look forward to seeing the results of the clinical trials.

The idea is that the battery-powered device, which is about the size of a mobile phone, stimulates nerve fibres, leading to increased blood flow.

Doctors at the Chang Gung Memorial Hospital in Taiwan plan to test it.

The best time to take your medication. This week: Diuretics

Used to treat heart failure and high blood pressure, diuretics or water tablets increase the amount of salt and water that comes out of your body in your urine.

Too much salt in the body can cause extra fluid to build up in the blood vessels, raising blood pressure. Diuretics lower blood pressure by flushing salt out of the body, taking unwanted extra fluid with it.

They also cause the walls of the blood vessels to relax and widen, making it easier for blood to flow and so reducing blood pressure.

The downside of the medication is more trips to the toilet.

Doctors advise the best time to take the pills is in the morning. The effects last for six hours. If you need a second dose, take it by mid-afternoon to avoid extra loo trips at night.

Altruist Anti-Redness and Pigmentation Cream has SPF50 in it and also works as a concealer, so its ideal for those with rosacea or other sensitive skin conditions (12.50, 50ml, amazon.co.uk).

How parenthood affects your health. This week: Weight gain

Having children is linked to a long-term increased risk of obesity in women.

A 2005 study of more than 2,000 women, published in the journal Preventative Medicine, found that for each child a woman has, her risk of obesity increases by 7 per cent.

After taking into account factors such as age, marital status and physical activity levels, researchers found that rates of obesity were significantly higher among women who had more children.

Our results suggest pregnant women, especially those with several children, are an important high-risk population for obesity in later life, they said.

The weight gain may be caused by insulin resistance, which is greater in women with more children, as pregnancy can alter glucose metabolism. Another cause could be stress.

Go here to read the rest:
Implant that gives failing hearts a boost! - Infosurhoy

Read More...

The Benefit of Hands-On Experience in Biotechnology Graduate Programs – Azusa Pacific University

March 12th, 2020 8:50 am

Biotechnology is not only an exciting career that covers a broad range of career fields engaged in advancing medical technologyits also a quickly growing job choice. In fact, according to Grand View Research, the biotechnology market is expected to reach $727.1 billion by 2025.

The skills and experience that students can gain from biotechnology graduate programs are crucial to excelling in this rapidly evolving field. But not all biotechnology graduate programs are created the samewhile its essential to master the curriculum, some lessons are better grasped through hands-on experience and training.

This is what sets Azusa Pacific Universitys M.S. in Biotechnology apart. The program focuses on internships and masters projects with pharmaceutical, biopharmaceutical, and medical device companies.

Academic laboratories are crucial and, at APU, courses are taught by industry professionals. But with the biotech industry changing continually, it can be a challenge for students to experience current technical advances unless theyre directly in the field. APUs program incorporates onsite internship experiences to ensure every program graduate is well-versed in the industry landscape.

Almost half of the top biotech companies are headquartered in California, in cities likes San Francisco and Los Angeles. APU is just 26 miles from L.A., which gives biotech students many opportunities to work alongside top professionals in the field. Students collaborate with companies like Gilead Sciences, Amgen, and Medtronic, where theyre able to observe state-of-the-art technical practices currently used in the industry. David Dyer, Ph.D., executive director of APUs M.S. in Biotechnology program, explained that this experience also allows students to understand aspects of a companys work environment, including communication, team function, leadership, and management style.

The goal is for grad students to obtain the skills needed to go from classroom to career field seamlessly.

A second reason the M.S. in Biotechnology program emphasizes in-person work with companies is that the company can get a long look at the student as a potential future hire, said Dyer. Companies can also place students on projects where they may require additional assistance.

Justin Hoang, a current biotech student, said that his internship with Grifols was a valuable learning experience. I learned how to operate new systems and software that pertained to the career I wish to pursue after graduation, he noted.

Graduates of APUs biotech program receive a head start on their rsums as well, as theyre able to list their experience with widely recognizable companies. The program prepares individuals for a variety of biotech careers, including those in epidemiology, genetic counseling, and microbiology.

APU alum Najeh Salamah enrolled in the M.S. in Biotechnology program after being away from school for a while. Salamah said, The well-rounded program sets you up for success, and you dont have to be a traditional biology/chemistry major.

Students of the program are required to complete 900 hours of onsite training, so every graduate will be adequately exposed to corporate practice and culturebut you wont be alone throughout the program. Salamah said that the programs faculty, counselors, and director are like family and work to guide their classes to have fruitful and compelling interaction. The faculty want their students to succeed and work to make everyone feel welcome.

Are you interested in becoming part of the biotech family at Azusa Pacific University and working toward your M.S. in Biotechnology? Learn more about the programs associated coursework and academic requirements.

Posted: March 10, 2020

See the article here:
The Benefit of Hands-On Experience in Biotechnology Graduate Programs - Azusa Pacific University

Read More...

Global Animal Biotechnology Industry Insights, 2018-2028 Featuring Profiles of ~124 Players and 110 Collaborations – Yahoo Finance

March 12th, 2020 8:50 am

Dublin, March 10, 2020 (GLOBE NEWSWIRE) -- The "Animal Biotechnology - Technologies, Markets and Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering.

Share of biotechnology-based products and services in 2018 is analyzed and the market is projected to 2028. The text is supplemented with 36 tables and 6 figures. Selected 260 references from the literature are appended.

Approximately 124 companies have been identified to be involved in animal biotechnology and are profiled in the report. These are a mix of animal healthcare companies and biotechnology companies. Top companies in this area are identified and ranked. Information is given about the research activities of 11 veterinary and livestock research institutes. Important 110 collaborations in this area are shown.

The report contains information on the following:

This report describes and evaluates animal biotechnology and its application in veterinary medicine and pharmaceuticals as well as improvement in food production. Knowledge of animal genetics is important in the application of biotechnology to manage genetic disorders and improve animal breeding. Genomics, proteomics and bioinformatics are also being applied to animal biotechnology.

Transgenic technologies are used for improving milk production and the meat in farm animals as well as for creating models of human diseases. Transgenic animals are used for the production of proteins for human medical use. Biotechnology is applied to facilitate xenotransplantation from animals to humans. Genetic engineering is done in farm animals and nuclear transfer technology has become an important and preferred method for cloning animals. There is a discussion of in vitro meat production by culture.

Biotechnology has potential applications in the management of several animal diseases such as foot-and-mouth disease, classical swine fever, avian flu and bovine spongiform encephalopathy. The most important biotechnology-based products consist of vaccines, particularly genetically engineered or DNA vaccines. Gene therapy for diseases of pet animals is a fast developing area because many of the technologies used in clinical trials humans were developed in animals and many of the diseases of cats and dogs are similar to those in humans.RNA interference technology is now being applied for research in veterinary medicine

Molecular diagnosis is assuming an important place in veterinary practice. Polymerase chain reaction and its modifications are considered to be important. Fluorescent in situ hybridization and enzyme-linked immunosorbent assays are also widely used. Newer biochip-based technologies and biosensors are also finding their way in veterinary diagnostics.

Biotechnology products are approved by the Center for Veterinary Medicine of the FDA. Regulatory issues relevant to animal biotechnology are described.

List of Topics Covered

Executive Summary1. Introduction to Animal Biotechnology2. Application of Biotechnology in Animals3. A Biotechnology Perspective of Animals Diseases4. Molecular Diagnostics in Animals5. Biotechnology-based Veterinary Medicine6. Research in Animal Biotechnology7. Animal Biotechnology Markets8. Regulatory Issues9. Companies Involved in Animal Biotechnology10. References

For more information about this report visit https://www.researchandmarkets.com/r/qbm3p5

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.comLaura Wood, Senior Press Managerpress@researchandmarkets.comFor E.S.T Office Hours Call 1-917-300-0470For U.S./CAN Toll Free Call 1-800-526-8630For GMT Office Hours Call +353-1-416-8900

Go here to read the rest:
Global Animal Biotechnology Industry Insights, 2018-2028 Featuring Profiles of ~124 Players and 110 Collaborations - Yahoo Finance

Read More...

Vir Biotechnology Announces Intent to Collaborate with Biogen on Manufacturing of Antibodies to Potentially Treat COVID-19 – GlobeNewswire

March 12th, 2020 8:50 am

SAN FRANCISCO, March 12, 2020 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc.(Nasdaq: VIR) today announced that it has signed a letter of intent with Biogen Inc. (Nasdaq: BIIB) for the development and clinical manufacturing of human monoclonal antibodies for the potential treatment of COVID-19, the disease caused by the SARS-CoV-2 virus. Because of the urgency of the situation, the companies have begun work while a Clinical Development and Manufacturing Agreement is being negotiated. Subject to the completion of a definitive agreement, Biogen would continue cell line development, process development, and clinical manufacturing activities in order to advance the development of Virs proprietary antibodies.

These exceptional circumstances presented by the threat of COVID-19 require that we work with great urgency in the interest of the public good, said George Scangos, Ph.D., CEO, Vir. Biogen is one of the global leaders in cell line and process development for advanced biologics; tapping into their capabilities will provide us with a U.S. base for supply and manufacture of antibody therapies.

Vir has identified a number of monoclonal antibodies that bind to SARS-CoV-2, which were isolated from individuals who had survived a SARS (Severe Acute Respiratory Syndrome) infection. The company is conducting research to determine if its antibodies, or additional antibodies that it may be able to identify, can be effective as treatment and/or prophylaxis against SARS-CoV-2.

About Virs Antibody Platform

Vir has a robust method for capitalizing on unusually successful immune responses naturally occurring in people who are protected from, or have recovered from, infectious diseases. The platform is used to identify rare antibodies from survivors that have the potential to treat and prevent rapidly evolving and/or previously untreatable pathogens via direct pathogen neutralization and immune system stimulation. Vir engineers the fully human antibodies that it discovers to enhance their therapeutic potential. This platform has been used to identify and develop antibodies for pathogens including Ebola (mAb114, currently in use in theDemocratic Republic of Congo), hepatitis B virus, influenza A, malaria, and others.

AboutVir Biotechnology

Vir Biotechnology is a clinical-stage immunology company focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. Vir has assembled four technology platforms that are designed to stimulate and enhance the immune system by exploiting critical observations of natural immune processes. Its current development pipeline consists of five product candidates targeting hepatitis B virus, influenza A, human immunodeficiency virus, and tuberculosis. For more information, please visit http://www.vir.bio.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as may, will, expect, plan, anticipate, estimate, intend, potential and similar expressions (as well as other words or expressions referencing future events, conditions or circumstances) are intended to identify forward-looking statements. These forward-looking statements are based on Virs expectations and assumptions as of the date of this press release. Each of these forward-looking statements involves risks and uncertainties. Actual results may differ materially from these forward-looking statements. Forward-looking statements contained in this press release include statements regarding the companys efforts to neutralize the SARS-CoV-2 virus and identify additional potential therapies for SARS-CoV-2, its ability to address the emerging public health epidemic, and its ability to enter into an agreement with Biogen, and its ability to secure a U.S. base for supply and manufacture of antibody therapies. Many factors may cause differences between current expectations and actual results including unexpected safety or efficacy data observed during preclinical or clinical studies, challenges in neutralizing SARS-CoV-2, difficulty in reaching a definitive agreement with Biogen, challenges of collaborating with other companies or government agencies, and challenges in accessing manufacturing capacity. Other factors that may cause actual results to differ from those expressed or implied in the forward-looking statements in this press release are discussed in Virs filings with theU.S. Securities and Exchange Commission, including the section titled Risk Factors contained therein. Except as required by law, Vir assumes no obligation to update any forward-looking statements contained herein to reflect any change in expectations, even as new information becomes available.

Contact:Vir Biotechnology, Inc.Investors Neera Ravindran, MDHead of Investor Relations & Strategic Communications nravindran@vir.bio+1-415-506-5256

Media Lindy Devereux Scient PR lindy@scientpr.com +1-646-515-5730

Original post:
Vir Biotechnology Announces Intent to Collaborate with Biogen on Manufacturing of Antibodies to Potentially Treat COVID-19 - GlobeNewswire

Read More...

Nutrition influences the course of MS – European Biotechnology

March 12th, 2020 8:50 am

New data prove that propionic acid modulates the intestine-mediated immune regulation in people with multiple sclerosis (MS).

In Cell the team headed by Aiden Haghikia from University Bochum demonstrated that the administration of propionic acid (PA) in addition to MS standard therapy reduced the relapse rate and the risk of disability increase in the long term. Furthermore, MRI studies indicate that propionic acid may reduce brain shrinkage of patients with Multiple sclerosis (MS), which is regarded as a measure for neuronal cell death.

Haghikia et al. demonstrated that

PA is reduced in MS patients, particularly early after disease manifestation; PA reduction is associated with an altered gut microbiome composition; after 14days of PA supplementation, Treg cell/TH17 imbalance was restored; longitudinal PA supplementation might have clinical implications.

The reseach team together with co-working groups at MDC Berlin and University of Halle-Wittenberg demonstrated that the microbiome composition is altered in MS patients. In addition, for the first time they were able to show a deficiency of propionic acid in the stool and serum of MS patients, which was most pronounced in the earliest phase of the disease. Propionic acid is an EFSA-approved antibacterial food supplement.

"Intestinal bacteria can directly and indirectly influence anatomically distant structures such as the brain," explained study head Haghikia, who together with Flexopharm Brain GMBH & Co. KG holds a patent on the invention. The company markets a related food supplement. "The intestinal microbiome thus corresponds to an independent endocrine organ that is in contact with the environment."

In the current study, the scientists transfered results previously obtained in cell culture and disease models co-developed witha group from Bar-Ilan University in Israel to MS patients: short-chain fatty acids such as propionic acid or its salt propionate led to the increased formation and increased function of T regulatory cells (Tregs) of the immune system. "These cells stop excessive inflammatory reactions and reduce auto-immune cells in the context of autoimmune diseases such as MS," said co-author Ralf Gold, Director of Neurology at St. Josef Hospital. The increase in Treg function is due to improved energy utilization through an altered function of the mitochondria.

However, the short-chain fatty acids represent only a fraction of the metabolic products of intestinal bacteria. "Further research into this largely unknown organ and the knowledge gained from it will make it possible to develop further innovative dietary measures to complement the known therapeutics in the future," commented Haghikia.

See original here:
Nutrition influences the course of MS - European Biotechnology

Read More...

The Daily Biotech Pulse: Mesoblast To Test Candidate On Coronavirus Symptoms, Proxy Battle Ahead For Rockwell Medical, Glaukos to Join S&P SmallCap…

March 12th, 2020 8:50 am

Here's a roundup of top developments in the biotech space over the last 24 hours:

(Biotech stocks that hit 52-week highsMarch 9.)

(Biotech stocks that hit 52-week lows March 9.)

See also:Attention Biotech Investors: Mark Your Calendar For These March PDUFA Dates

Mesoblast limited (NASDAQ: MESO) said it plans to evaluate its allogenic mesenchymal stem cell product candidate remestemcel-L in patients with acute respiratory distress syndrome caused by COVID-19 in the U.S., Australia, China and Europe.

The company said it is in active discussions with various government and regulatory authorities, medical institutions and pharma companies.

In premarket trading Tuesday, the shares were surging 28.35% to $7.90.

Emergent Biosolutions Inc (NYSE: EBS) said it has entered into an agreement with Novavax, Inc. (NASDAQ: NVAX), under which the former will use its molecule-to-market contract development and manufacturing service to support bringing intothe latter's vaccine candidate to protect against COVID-19 into the clinic.

Emergent will produce the COVID-19 experimental vaccine candidate developed using Novavax's proprietary recombinant protein nanoparticle technology platform. Emergent said it has initiated work and anticipatescommencement of a Phase 1 study within the next four months.

Separately, Novavax said the Coalition for Epidemic Preparedness awarded it an initial funding of $4 million to support its COVID-19 vaccine program.

In premarket trading Tuesday, Emergent shares were adding 0.95% to $53.02 and Novavax shares were surging up 24.35% to $12.46.

GENMAB A/S/S ADR (NASDAQ: GMAB) announced the appointment of Anthony Mancini as EVP and COOeffective March 23. Mancini's rolecalls for himto oversee the company's commercial, corporate development, business development and information technology functions.

Ophthalmic medtech and pharma company Glaukos is set to join the S&P SmallCap 600 Index, effective prior to the open of trading March 13, replacing AK Steel Holding Corporation (NYSE: AKS), which has agreed to be acquired by Cleveland-Cliffs Inc (NYSE: CLF).

Glaukos shares were trading 7.5% higher at $38.49 in the premarket session.

MediciNova, Inc. (NASDAQ: MNOV) said it plans to initiate the development of MN-166 for severe pneumonia and acute respiratory distress syndrome following positive results in a recent preclinical study in an animal model. The animal study showed treatment with the investigational candidate reversed histological changes, including inflammation, hemorrhage, alveolar congestion and alveolar edema.

Medical Resources Acquisition said on Feb. 25 it offered Rockwell Medical Inc (NASDAQ: RMTI) $15 million in equity investment for three board seatscurrently held by John Cooper, Mark Ravich and Lisa Colleran.

The investment firm said Rockwell's board hasfailed to provide appropriate governance, resulting in reckless spending, acash deficiency and a lack of operational controls that have impacted stock performance.

Rockwell acknowledged receiving an email from Medical Resources Acquisition in a press release.

"The Board of Directors is in the process of reviewing the materials submitted by MRAG. Stockholders do not need to take any action at this time," the company said.

The stock was trading 9.37% higher at $3.50 in Tuesday's premarket session.

Acceleron Pharma Inc (NASDAQ: XLRN) saidtreatment with ACE-083 in patients with Charcot-Marie-Tooth disease did not demonstrate functional improvement in aPhase 2 trial.

The companysaid it is discontinuing the development of ACE-083.

Organogenesis Holdings Inc's (NASDAQ: ORGO) fourth-quarter revenues climbed 17% to $74.6 million. The net loss per share narrowed from 12 cents to 4 cents. For 2020, the company guided to revenues of $273 million to $277 million. The results as well as the guidance were above consensus.

The stock jumped 14.56% to $3.54 in after-hours trading.

Aduro BioTech Inc (NASDAQ: ADRO) said its fourth-quarter revenues increased from $2.8 million in 2018 to $3.6 million in 2019. The loss per share narrowed from 33 cents to 24 cents, while analysts expected a narrower loss of 21 cents per share.

The stock slipped 4.89% to $2.92 in after-hours trading.

Assertio Therapeutics Inc (NASDAQ: ASRT) reported fourth-quarter revenues of $59.23 million and a loss of $2.65 per share. In the year-ago quarter, the company reported revenues of $42.6million and a loss of 38 cents per share. On a non-GAAP basis, the company reported a loss of 14 cents per share for the recent quarter compared to expectations for a profit of 14 cents per share.

The stock fell 11.21% to 95 cents in after-hours trading.

The FDA is set to rule on Bristol-Myers Squibb Co's (NYSE: BMY) sBLA for Opdivo + Yervoy as treatment option for patients with advanced hepatocellular carcinoma who werepreviously treated with Bayer AG (OTC: BAYRY) and Onyx Pharma's Nexavar.

Related Link: The Week Ahead In Biotech (March 8-14): Bristol-Myers Awaits FDA Nod For Liver Cancer Combo Therapy, Earnings Flow Continues

2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

See the original post:
The Daily Biotech Pulse: Mesoblast To Test Candidate On Coronavirus Symptoms, Proxy Battle Ahead For Rockwell Medical, Glaukos to Join S&P SmallCap...

Read More...

The Week Ahead In Biotech (March 8-14): Bristol-Myers Awaits FDA Nod For Liver Cancer Combo Therapy, Earnings Flow Continues – Benzinga

March 12th, 2020 8:50 am

Biotech stocks rebounded in the week ended March 6, recovering from the previous week's steep sell-off.

The week was light on news flow, barring some smid-cap earnings andCOVID-19 treatment and vaccine news.

The following arekey catalysts in the unfolding week that a biotech investor should stay tuned to.

Barclays Global Healthcare Conference: March 10-12 in Miami, Florida.American Academy of Allergy Asthma and Immunology, or AAAAI, Annual Meeting: March 13-16 in Philadelphia, Pennsylvania.

The FDA is set to rule on Bristol-Myers Squibb Co's (NYSE: BMY) sBLA for Opdivo + Yervoy as a treatment option for patients with advanced hepatocellular carcinoma who were previously treated with Bayer AG (OTC: BAYRY) and Onyx Pharma's Nexavar. The PDUFA date has been set for Tuesday.

Blueprint Medicines Corp (NASDAQ: BPMC) is scheduled to present at the AAAAI annual meeting with Phase 2 data for Avapritinib, which is being evaluated for treating indolent and smoldering systemic mastocytosis.

See also: Attention Biotech Investors: Mark Your Calendar For These March PDUFA Dates

Monday

Tuesday

Wednesday

Friday

Imara, a biopharma company that is developing therapies for rare hemoglobinopathies, has filed to offer 4.45 million shares in an IPO, to be priced between $16 and $18. The company seeks to list its shares on the Nasdaq under the ticker symbol "IMRA."

Revolution Medicines Inc (NASDAQ: RVMD)

Related Link: How The COVID-19 Outbreak Is Benefiting Biotech Investors

2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original post:
The Week Ahead In Biotech (March 8-14): Bristol-Myers Awaits FDA Nod For Liver Cancer Combo Therapy, Earnings Flow Continues - Benzinga

Read More...

UNITY Biotechnology, Inc. Reports Fourth Quarter and Full Year 2019 Financial Results – GlobeNewswire

March 12th, 2020 8:50 am

SOUTH SAN FRANCISCO, Calif., March 11, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging, today reported financial results for the fourth quarter and full year ended December 31, 2019. Unity issued a press release providing pipeline and business updates on February 25, 2020.

Fourth Quarter and Full Year 2019 Financial Results

Cash, cash equivalents and investments totaled $125.0 million as of December 31, 2019 compared with $171.1 million as of December 31, 2018.

Operating loss for the twelve months ended December 31, 2019 was $89.7 million compared to $79.5 million for the twelve months ended December 31, 2018. Cash used in operations during the year ended 2019 was $72.4 million compared to $56.6 million for the year ended 2018. Total operating loss for the three months ended December 31, 2019 was $23.1 million compared to $22.8 million for the fourth quarter of 2018. Cash used in operations during the fourth quarter of 2019 was $15.7 million compared to $12.8 million for the fourth quarter of 2018.

Research and development expenses were $71.0 million for the year ended December 31, 2019 compared to $58.9 million for the year ended December 31, 2018. The increase of $12.1 million was primarily due to a net increase of $2.3 million for personnel-related expenses, which was partially offset by a decrease of $1.1 million related to non-cash stock compensation expense,$6.7 million for outside research and development activities and $3.1 million in lab and facilities-related costs. Research and development expenses were $18.2 million for the three months ended December 31, 2019 compared to $16.3 million for the three months ended December 31, 2018. The increaseof $1.9 million was primarily due to $0.5 million for personnel-related expenses and $1.1 million for outside research and development activities.

General and administrative expenses were $20.0 million for the year ended December 31, 2019 compared to $16.0 million for the year ended December 31, 2018. The increase of $4.0 million was primarily due to an increase of $3.4 million for personnel-related expenses, of which $2.5 millionwas related to non-cash stock compensation expense,and $0.6 million in insurance-related expenses, partially offset by $0.5 million decrease in professional fees. General and administrative expenses were $4.9 million for the three months ended December 31, 2019 compared to $4.3 million for the three months ended December 31, 2018.The $0.6 million increase was primarily due to personnel-related costs, primarily attributable to non-cash stock-based compensation expense.

About UNITYUNITY is developing therapeutics to extend healthspan with an initial focus on cellular senescence. UNITY believes that the accumulation of senescent cells is a fundamental mechanism of aging and a driver of many common age-related diseases. Cellular senescence is a natural biological state in which a cell permanently halts division. As senescent cells accumulate with age, they begin secreting inflammatory factors, proteases, fibrotic factors, and growth factors, that disturb the tissue micro-environment. This collection of secreted proteins is referred to as the Senescence Associated Secretory Phenotype, or SASP. UNITY is developing senolytic medicines to eliminate senescent cells and thereby stop the production of the SASP, which UNITY believes addresses a root cause of age-related diseases. By stopping the production of the SASP at it source, UNITY believes senolytic medicines could slow, halt, or reverse diseases such as osteoarthritis and age-related eye diseases.More information is available atwww.unitybiotechnology.comor follow us onTwitter.

Forward-Looking StatementsThis press release contains forward-looking statements including statements related to the potential for UNITY to develop therapeutics to extend healthspan. These statements involve substantial known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from the information expressed or implied by these forward-looking statements. We may not actually achieve the plans, intentions or expectations disclosed in our forward-looking statements, and you should not place undue reliance on our forward-looking statements. Actual results or events could differ materially from the plans, intentions and expectations disclosed in the forward-looking statements we make. The forward-looking statements in this press release represent our views as of the date of this release. We anticipate that subsequent events and developments will cause our views to change. However, while we may elect to update these forward-looking statements at some point in the future, we have no current intention of doing so except to the extent required by applicable law. You should, therefore, not rely on these forward-looking statements as representing our views as of any date subsequent to the date of this release. For a further description of the risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to the business of the Company in general, see UNITYs most recently filed Quarterly Report on Form 10-Q for the quarter ended September 30, 2019, filed with the Securities and Exchange Commission on November 6, 2019, as well as other documents that may be filed by UNITY from time to time with the Securities and Exchange Commission.

Investors Endurance AdvisorsPeter Rahmerprahmer@enduranceadvisors.com

Media Canale CommunicationsJason Sparkjason@canalecomm.com

Link:
UNITY Biotechnology, Inc. Reports Fourth Quarter and Full Year 2019 Financial Results - GlobeNewswire

Read More...

Page 636«..1020..635636637638..650660..»


2025 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick